For the Inventor, By the Inventor

Enter assignee name

Bedford, MA, United States of America

Conagen Inc.

USPTO Granted Patents = 62

% Expired Patents = 1.6

CIPO Patents = 6

EPO Patents = 15

Trademarks = 5

Forward Citations = 383

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Xiaodan Yu (42 out of 48 patents)

Guohong Mao (41 out of 41 patents)

Oliver Yu (10 out of 10 patents)

4. Hui Chen (10 out of 11 patents)

5. Michael Batten (9 out of 9 patents)

6. Venkata Sai Prakash Chaturvedula (9 out of 29 patents)

7. Jacob Edward Vick (6 out of 6 patents)

8. Yang Luo (5 out of 6 patents)

9. Nicky Caiazza (5 out of 24 patents)

10. Yilin Wu (4 out of 4 patents)

11. Hongxue Wang (4 out of 4 patents)

12. Beihua Zhang (3 out of 3 patents)

13. David Byun (3 out of 3 patents)

14. Maung Nyan Win (3 out of 5 patents)

15. Jun Urano (3 out of 16 patents)

Core Competencies:

Eriodictyol

Steviol Glycosides

Capsaicinoids

Lactones

Plasmid Addiction

Beta-Glucosidase

Glycoproteins

Acyl-CoA Synthetase

O-Methyltransferase

Whole-Cell Catalysts

Microbial Ergothioneine

Regulatory Elements

62 patents: Sort by Forward Citations

1. 12668826 - BIOSYNTHETIC PRODUCTION OF VARIANT STEVIOL GLYCOSIDES (2026-06-30),

2. 12668804 - BIOSYNTHESIS OF ERIODICTYOL (2026-06-30),

3. 12624363 - PLASMID ADDICTION SYSTEM TO DRIVE DESIRED GENE EXPRESSION (2026-05-12),

4. 12480147 - BIOSYNTHETIC PRODUCTION OF GAMMA-LACTONES (2025-11-25),

5. 12416028 - Biosynthetic production of gamma- and delta-lactones using cytochrome P450 enzymes having subterminal hydroxylase activity (2025-09-16),

6. 11946083 - Method for the microbial production of specific natural capsaicinoids (2024-04-02),

7. 11911497 - Rebaudioside E and food products sweetened with rebaudioside E (2024-02-27),

8. 11884694 - Non-caloric sweeteners and methods for synthesizing (2024-01-30),

9. 11873497 - Regulatory elements from labyrinthulomycetes microorganisms (2024-01-16),

10. 11680281 - Biosynthetic production of steviol glycosides and processes therefore (2023-06-20),

11. 11549131 - Biosynthetic production of gamma-lactones (2023-01-10),

12. 11459591 - Method for the microbial production of specific natural capsaicinoids (2022-10-04),

13. 11453692 - Non-caloric sweeteners and methods for synthesizing (2022-09-27),

14. 11447808 - Biosynthetic production of steviol glycoside rebaudioside I via variant enzymes (2022-09-20),

15. 11441165 - Biosynthetic production of steviol glycosides rebaudioside J and rebaudioside N (2022-09-13),

Company Overview

Conagen Inc., based in Bedford, MA, specializes in biosynthetic production, leveraging advanced biotechnology to develop innovative solutions in various sectors. The company focuses on the synthesis of natural compounds, including eriodictyol, steviol glycosides, capsaicinoids, and lactones, utilizing cutting-edge techniques such as plasmid addiction and beta-glucosidase applications. Conagen's expertise in glycoproteins and acyl-CoA synthetase positions it as a leader in sustainable biomanufacturing, addressing the growing demand for natural ingredients across industries.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

62 Patents

#13 in Bedford, MA

#328 in Massachusetts

#5,848 in US

#11,779 in the World

Bedford, MA, United States of America

Conagen Inc.

Forward Citations = 383

31 inventors:

Xiaodan Yu (42 out of 48 patents)

Guohong Mao (41 out of 41 patents)

Oliver Yu (10 out of 10 patents)

4. Hui Chen (10 out of 11 patents)

5. Michael Batten (9 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Conagen Inc.. Retrieved from https://idiyas.com/company/conagen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…